Seiji Hashimoto

This inventor holds 20 USPTO granted patents, primarily in Cyclic Peptide Chemistry. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1987-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiji Hashimoto. Retrieved from https://idiyas.com/inventor/seiji-hashimoto-7ye1xuxh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20

% Patents Active = 95.0

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 71(Granted Patents)

Location History:

Deguchicho, JP (1987)
Umezono, JP (1990)
Tsukuba, JP (1991 - 2003)
Ibaraki, JP (2004)

Company Filing History:

20 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1987-2004

Loading Chart...

Areas of Expertise:

Cyclic Lipopeptide

Acylase

Antimicrobial Activity

Deacylation Process

Cyclic Hexapeptides

Echinocandine Derivatives

Peptide Compounds

Carboxylic Acid Derivatives

FR900482

WF16616

Therapeutic Agent

New Compound FR-900451

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6825003 - Cyclic lipopeptide acylase (2004-11-30),

2. 6573084 - Process for the deacylation of cyclic lipopeptides (2003-06-03),

3. 6537789 - Process for the deacylation of cyclic lipopeptides (2003-03-25),

4. 6423530 - Process for preparing FR900482 and compounds analogous thereto (2002-07-23),

5. 6399567 - Cyclic hexapeptides having antibiotic activity (2002-06-04),

6. 6372474 - Cyclic lipopeptide acylase (2002-04-16),

7. 6331521 - Echinocandine derivatives with antimicrobial activity (2001-12-18),

8. 6207434 - Process for the deacylation of cyclic lipopeptides (2001-03-27),

9. 6204031 - Process for preparing FR900482 and compounds analogous thereto (2001-03-20),

10. 6146872 - Cyclic lipopeptide acylase (2000-11-14),

11. 5952299 - Cyclic peptide nuclei and derivatives thereof (1999-09-14),

12. 5932737 - Peptide compounds for treatment of no-mediated diseases (1999-08-03),

13. 5854276 - Substance WF16616, process for production thereof, and use thereof (1998-12-29),

14. 5547934 - WF11243 substance (1996-08-20),

15. 5514715 - Antimicrobial agent, FR109615 and production thereof (1996-05-07),

Title: Seiji Hashimoto: Innovator in Cyclic Lipopeptide Research

Introduction

Seiji Hashimoto is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to the field of cyclic lipopeptides. With a remarkable portfolio of 20 patents, he has made strides in innovative pharmaceutical processes, particularly in the area of drug development.

Latest Patents

His latest patents include groundbreaking work on cyclic lipopeptide acylase and a process for the deacylation of cyclic lipopeptides. These innovations are poised to enhance the efficiency and effectiveness of pharmaceutical manufacturing processes.

Career Highlights

Hashimoto is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he applies his extensive knowledge and expertise to further the company’s research capabilities. His work plays a crucial role in developing new therapeutic options that can address unmet medical needs.

Collaborations

Throughout his career, Hashimoto has collaborated with notable colleagues, including Michio Yamashita and Masami Ezaki. These partnerships have fostered a creative environment that drives innovation and contributes to the advancement of science in the pharmaceutical sector.

Conclusion

Seiji Hashimoto stands out as an influential figure in the realm of biotechnology and pharmaceuticals. His dedication to innovation continues to shape the future of medicine through his numerous patents and collaborative efforts, making a lasting impact in the industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]